FDA Proposed Adverse Event Hotline Criteria Too Broad, NACDS Says
Executive Summary
FDA's proposed rule on adding a toll-free number to the agency's MedWatch adverse event reporting system should only apply to new molecular entities, the National Association of Chain Drug Stores says
You may also be interested in...
Adverse Event Reporting Hotline Being Refined Through FDA Labeling Study
FDA is honing in on the wording for the adverse event statement to be included on labeling as part of the agency's proposed rule to add a toll-free number to the MedWatch adverse event reporting system
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011